|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Non-Alcoholic Steatohepatitis Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Vitamin E and Pioglitazone, Obeticholic Acid (OCA), Lanifibranor, Semaglutide, Resmetirom, Aramchol, Cenicriviroc, Others), By End-User (Hospital Pharmacies, Retail and Specialty Pharmacies, Others), By Region & Competition, 2019-2029F ... Acid (OCA) Lanifibranor Semaglutide Resmetirom Aramchol Cenicriviroc Others Non-Alcoholic Steatohepatitis ... Non-Alcoholic SteatoHepatitis (NASH): An Analysis of Disease Prevalence, Drugs in development, Regulatory guidelines and Market opportunity in Various Geographies Sales of Hepatitis C drugs crossed ~$10bn in 2014 proving that treatments for liver disease could become mega-blockbusters and Non-Alcoholic SteatoHepatitis (NASH) is expected to be equally lucrative. Improved diagnosis rate and change in treatment ... Rising Stars Outlook 2016: New Emergence of Potential Tx & Dx Options could transform the Current Landscape for Liver Diseases (NASH) Non-Alcoholic SteatoHepatitis (NASH) is an unmet medical need and is becoming the leading cause of liver transplant. No FDA-approved therapies and a meager diagnosis, it poses a unique challenge in the design of studies for NASH. Therefore, there is a ... Global NASH (Non –Alcoholics Steatohepatitis) Market: Trends, Opportunities and Forecasts (2015-2030) (By Region, By Drugs – Off Label & Special Treatment Drugs, Aramachol, Clinical Pipeline, GR-MD-02, GFT 505 Market) Executive Summary Progressive numbers of Liver disorders along with rise in obesity will fuel the demand for NASH Drugs The Global NASH Market is growing at a moderate rate over last five years on account of rising number of obesity among young population ... Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H2 2017 Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H2 2017 SUMMARY According to the recently published report 'Acyl CoA Desaturase - Pipeline Review, H2 2017'; Acyl CoA ... Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H1 2018 Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H1 2018 SUMMARY Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or ... Global Nonalcoholic Steatohepatitis (NASH) Market Report 2021 ... Ocaliva (OCA) Cenicriviroc (CVC) Selonsertib Aramchol Industry Segmentation Hospitals Clinics Channel ... Global Non-alcoholic Steatohepatitis Market Report 2021 ... Ocaliva (OCA) Cenicriviroc (CVC) Selonsertib Aramchol Industry Segmentation Hospitals Clinics Channel ... Global Acyl CoA Desaturase Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 ... at a % CAGR in next six years. While Aramchol segment is altered to a % CAGR between 2022 ... markets. Market segment by Type, covers Aramchol T-3764518 TSN-2898 Others Market ... Global Nonalcoholic Steatohepatitis Therapeutics Market Report 2021 ... —— Product Type Segmentation Obeticholic Acid Aramchol Saroglitazar Elafibranor Industry Segmentation Hospital ... Global Acyl CoA Desaturase Market Growth 2025-2031 ... regions and countries. Segmentation by Type: Aramchol T-3764518 TSN-2898 Others Segmentation ... Non-alcoholic Steatohepatitis Treatment Market Size, Share & Trends Analysis Report By Drug (Vitamin E & Pioglitazone, Resmetirom), By Disease Stage, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 ... ' Obeticholic acid, Galmed Pharmaceuticals Ltd.'s Aramchol, NovNordisk A/S's Semaglutide, and Madrigal Pharmaceuticals ... Global Non- Alcoholic Steatohepatitis Treatment Market Research Report 2023 ... Madrigal Pharmaceuticals Segment by Type Cenicriviroc Aramchol Resmetirom Semaglutide Lanifibranor Obeticholic Acid ... Nonalcoholic Steatohepatitis (NASH): KOL Insight [2018] ... for the agent? Will Galmed’s Aramchol find a place in NASH? What do experts ... (Allergan) Mid-stage Pipeline Therapies Aramchol (Galmed Medical Research) BI 1467335 (Boehringer ... NASH: KOL Insight [2017] ... the study design? Emricasan and Aramchol are targeting different stages of NASH ... (Gilead) emricasan (Novartis/Conatus Pharmaceuticals) Aramchol (Galmed Pharmaceuticals) semaglutide (Novo Nordisk ... Acyl CoA Desaturase Market, Global Outlook and Forecast 2022-2028 ... China is Forecast to Reach $ Million by 2028. Aramchol Segment to Reach $ Million by 2028, with ... Market Segment Percentages, by Type, 2021 (%) Aramchol T-3764518 TSN-2898 Others Global ... Global Non-Alcoholic Steatohepatitis Treatment Market Growth (Status and Outlook) 2024-2030 ... Acid (OCA) Lanifibranor Semaglutide Resmetirom Aramchol Cenicriviroc Others Segmentation by application Hospital ... Global Non-Alcoholic Steatohepatitis Treatment Market 2025 by Company, Regions, Type and Application, Forecast to 2031 ... Acid (OCA) - Lanifibranor - Semaglutide - Resmetirom - Aramchol - Cenicriviroc - Others Market segment by Application ... Global Non- Alcoholic Steatohepatitis Treatment Market 2025 by Company, Regions, Type and Application, Forecast to 2031 ... markets. Market segment by Type Cenicriviroc Aramchol Resmetirom Semaglutide Lanifibranor Obeticholic Acid ... Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2029) The global non-alcoholic steatohepatitis (NASH) drugs market is expected to reach US$84.34 billion in 2029, growing at a CAGR of 39.13%, for the duration spanning 2018-2029. The factors such as rising healthcare expenditure, increasing pharmaceutical R&D ... |